Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression
Open accessAbstract
Control of HIV-1 gene expression depends on two viral regulatory proteins, Tat and Rev. Tat stimulates transcription elongation by directing the cellular transcriptional elongation factor P-TEFb to nascent RNA polymerases. Rev is required for the transport from the nucleus to the cytoplasm of the unspliced and incompletely spliced mRNAs that encode the structural proteins of the virus. Molecular studies of both proteins have revealed how they interact with the cellular machinery to control transcription from the viral LTR and regulate the levels of spliced and unspliced mRNAs. The regulatory feedback mechanisms driven by HIV-1 Tat and Rev ensure that HIV-1 transcription proceeds through distinct phases. In cells that are not fully activated, limiting levels of Tat and Rev act as potent blocks to premature virus production.
AI snapshot
Written from the paper’s full text.
TL;DR
This review describes how HIV-1 Tat and Rev coordinate viral gene expression by controlling transcription elongation and nuclear export of viral RNAs. It synthesizes decades of molecular, genetic, and structural work to explain the phased production of regulatory versus structural viral proteins and the feedback that can drive latency.
Key findings
- Tat binds the TAR RNA element (nucleotides +1 to +59) and recruits P-TEFb (CDK9/CycT1), activating CDK9 and leading to phosphorylation of NELF-E, RNAP II CTD, and Spt5; this releases paused elongation complexes and increases polymerase processivity.
- Rev binds the 351-nt RRE at a high-affinity site, then oligomerizes cooperatively; oligomerization raises affinity approximately 500-fold and enables Crm1-dependent export of unspliced 9-kb and incompletely spliced 4-kb mRNAs, whereas fully spliced 1.8-kb mRNAs are exported without Rev.
- HIV-1 uses four 5′ splice sites and eight 3′ splice sites to produce more than 40 spliced mRNA species, with cis-acting enhancer and silencer elements dominating splice-site selection over intrinsic splice-site strength.
- Programmed frameshifting occurs about 5% of the time, producing roughly one Gag-Pro-Pol precursor per 20 Gag precursors; Tat and Rev feedback creates distinct early and late expression phases and can force the provirus into latency when Tat or Rev levels fall below threshold.
Methods
- Narrative review; no new experiments or primary data are reported.
- Synthesizes published molecular virology, biochemistry, genetics, structural biology, and cell biology on Tat/TAR/P-TEFb, Rev/RRE/Crm1, the HIV-1 LTR, splicing, polyadenylation, RNA export, translation, and frameshifting.
- Main analysis is qualitative integration of cited primary studies and structural models; no systematic search strategy or meta-analysis is described.
Limitations
- The paper states that structures of TAR RNA with intact P-TEFb and of large P-TEFb/RNA polymerase elongation complexes remain unsolved; additional Tat-associated elongation factors may still be unidentified; coupling between elongation, splicing, polyadenylation, and export is a challenging unresolved problem; and mRNP remodeling plus host RNA-binding proteins affecting export and cytoplasmic use need further study.
- Evident from the text: as a narrative review, it lacks a systematic search, risk-of-bias assessment, or new quantitative synthesis, and portions of the provided text are OCR-garbled, which may obscure some details.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 153 cited sources checked · 0 supported · 0 flagged
- Premisenone given
Immediately after infection, HIV-1 produces only short completely spliced mRNAs encoding Tat and Rev.
“Immediately after infection, HIV-1 produces only short completely spliced mRNAs encoding the viral regulatory proteins Tat and Rev.”
Quote in the paperSubstantial claim - Interpretationnone given
Tat stimulates transcription elongation by recruiting the cellular elongation factor P-TEFb to nascent RNA polymerases.
“Tat stimulates transcription elongation by directing the cellular transcriptional elongation factor P-TEFb to nascent RNA polymerases.”
Quote in the paperSubstantial claim - Premisecitation
There is a strict correlation between TAR RNA binding to Tat in vitro and the ability of TAR sequences to support transactivation.
“Although there is a strict correlation between the ability of TAR RNA to bind to Tat in vitro and the ability of these sequences to support transactivation (Churcher et al. 1993), mutations in the apical loop of the TAR element that do not interfere with Tat binding also interfere with transactivation (Feng and Holland 1988).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Churcher et al. 1993
Not checked in the free run.
- Interpretationnone given
Regulatory feedback mechanisms driven by Tat and Rev cause HIV-1 transcription to proceed through distinct phases.
“The regulatory feedback mechanisms driven by HIV-1 Tat and Rev ensure that HIV-1 transcription proceeds through distinct phases.”
Quote in the paperSubstantial claim - Premisenone given
The larger incompletely spliced HIV-1 mRNAs encode Env and the accessory proteins Vif, Vpr, and Vpu.
“These encode Env and the HIV-1 accessory genes Vif, Vpr, and Vpu.”
Quote in the paperNot a substantial claim
- Premisecitation
P-TEFb is a critical cofactor for Tat activation of elongation.
“In parallel, the search for the “loop factor” and other cofactors for Tat also pointed to P-TEFb as a critical cofactor for Tat activation of elongation.”
Quote in the paperSubstantial claim - Premisenone given
After integration into the host genome, the HIV-1 provirus acts as a transcription template regulated at transcriptional and posttranscriptional levels.
“A fter integration into the host genome, the HIV-1 provirus acts as a transcription template that is regulated at the transcriptional and posttranscriptional levels.”
Quote in the paperSubstantial claim - Premisecitation
Tat recognition of TAR requires conformational changes in the RNA structure.
“Detailed analysis of Tat's interactions with TAR RNA by NMR subsequently revealed that Tat recognition of TAR requires conformational changes in the RNA structure (Fig. 1B).”
Quote in the paperNot a substantial claim - Interpretationreasoning
When cells are not fully activated, low amounts of Tat and Rev strongly prevent premature virus production.
“In cells that are not fully activated, limiting levels of Tat and Rev act as potent blocks to premature virus production.”
Quote in the paperSubstantial claim - Premisecitation
Tat is inactive in murine cells because murine CycT1 differs from human CycT1 by a single substitution of cysteine 261 for tyrosine.
“Tat is inactive in murine cells, because the murine CycT1 sequence differs from the human sequence by a single substitution of cysteine 261 for tyrosine.”
Quote in the paperSubstantial claim - Premisecitation
TAK, the Tat-associated kinase, binds tightly and specifically to Tat.
“Rice and his colleagues (Herrmann and Rice 1995;Herrmann et al. 1996) showed that a protein kinase complex, which they called TAK (Tat-associated kinase), binds tightly and specifically to Tat.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Herrmann and Rice 1995
Not checked in the free run.
- cites Herrmann et al. 1996
Not checked in the free run.
- Premisecitation
Mutations in the apical loop of TAR that do not interfere with Tat binding also interfere with transactivation.
“Although there is a strict correlation between the ability of TAR RNA to bind to Tat in vitro and the ability of these sequences to support transactivation (Churcher et al. 1993), mutations in the apical loop of the TAR element that do not interfere with Tat binding also interfere with transactivation (Feng and Holland 1988).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Feng and Holland 1988
Not checked in the free run.
- Premisecitation
CycT1 is essential for Tat activity.
“Second, persuasive genetic evidence showed that CycT1 is essential for Tat activity.”
Quote in the paperSubstantial claim - Premisecitation
Expression of reporter genes under control of the HIV-1 LTR depends on a transactivating factor named Tat.
“The first evidence that gene expression in HIV-1 also requires viral transacting factors came from experiments by Sodroski et al. (1985a,b) who noted that the expression of reporter genes placed under the control of the viral LTR was dependent on a transactivating factor, which they named Tat.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sodroski et al. (1985a,b)
Not checked in the free run.
- Premisecitation
Complex formation between Tat, P-TEFb, and TAR requires both the Tat binding site and the TAR loop sequence.
“Crucially, for a putative “loop factor,” complex formation between Tat, P-TEFb, and TAR requires both the Tat binding site and the loop sequence.”
Quote in the paperSubstantial claim - Premisecitation
P-TEFb is required for Tat-mediated transactivation.
“After these seminal biochemical observations, additional genetic and biochemical evidence showed unequivocally that P-TEFb is required for Tat-mediated transactivation.”
Quote in the paperSubstantial claim - Interpretationnone given
Rev is required for nuclear export of unspliced and incompletely spliced HIV-1 mRNAs that encode structural proteins.
“Rev is required for the transport from the nucleus to the cytoplasm of the unspliced and incompletely spliced mRNAs that encode the structural proteins of the virus.”
Quote in the paperSubstantial claim - Premiseown data
Tat activity requires the TAR regulatory element located downstream from the transcription initiation site between nucleotides +1 and +59.
“Deletion analysis of the viral LTR showed that Tat activity required the transactivation-responsive region (TAR), a regulatory element located downstream from the initiation site for transcription between nucleotides þ1 and þ59 (Fig. 1A).”
Quote in the paperSubstantial claim - Premisecitation
Binding of Tat to P-TEFb induces conformational changes in CDK9 that constitutively activate the enzyme.
“The binding of Tat to P-TEFb induces significant conformational changes in CDK9 that constitutively activate the enzyme (Wei et al. 1998;Isel and Karn 1999;Tahirov et al. 2010).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Wei et al. 1998
Not checked in the free run.
- cites Isel and Karn 1999
Not checked in the free run.
- cites Tahirov et al. 2010
Not checked in the free run.
- Premisecitation
Tat binding to TAR involves displacement of U23 by an arginine side chain in Tat's basic binding domain, creating a binding pocket in the major groove with the adjacent G26:C39 base pair.
“This refolding process involves displacement of the first residue in the bulge (U23) by one of the arginine side chains present in the basic binding domain of the Tat protein creating a binding pocket for the arginine side chain in the major groove together with the adjacent G26:C39 base pair (Puglisi et al. 1992;Aboul-ela et al. 1995;Brodsky and Williamson 1997;Davidson et al. 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Puglisi et al. 1992
Not checked in the free run.
- cites Aboul-ela et al. 1995
Not checked in the free run.
- cites Brodsky and Williamson 1997
Not checked in the free run.
- Premisenone given
Rev transports unspliced and incompletely spliced mRNAs encoding structural proteins from the nucleus to the cytoplasm.
“Rev transports the unspliced and incompletely spliced mRNAs encoding the structural proteins from the nucleus to the cytoplasm.”
Quote in the paperSubstantial claim - Premisenone given
Tat activates viral transcription by stimulating elongation from the HIV-1 LTR.
“Tat activates viral transcription by stimulating elongation from the viral long terminal repeat (LTR).”
Quote in the paperSubstantial claim - Premisecitation
CDK9 protein kinase inhibitors are selective inhibitors of HIV-1 transcription.
“First, a set of novel CDK-9 protein kinase inhibitors were shown to be selective inhibitors of HIV-1 transcription (Mancebo et al. 1997).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mancebo et al. 1997
Not checked in the free run.
- Interpretationnone given
HIV-1 gene expression is controlled by two viral regulatory proteins, Tat and Rev.
“Control of HIV-1 gene expression depends on two viral regulatory proteins, Tat and Rev.”
Quote in the paperSubstantial claim - Premisecitation
The HIV-1 LTR includes multiple upstream DNA regulatory elements that serve as binding sites for cellular transcription initiation factors.
“The HIV-1 LTR includes multiple upstream DNA regulatory elements that serve as binding sites for cellular transcription initiation factors (Rittner et al. 1995).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rittner et al. 1995
Not checked in the free run.
- Premisecitation
Proviruses assemble an ordered nucleosomal structure surrounding the promoter.
“As originally shown by Verdin et al. (1993), proviruses assemble an ordered nucleosomal structure surrounding the promoter.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Verdin et al. (1993)
Not checked in the free run.
- Premisecitation
HIV-1 preferentially integrates into active transcription units that provide a favorable environment for viral transcription.
“When HIV-1 infects cells, it preferentially integrates into active transcription units that provide a favorable environment for viral transcription (Lewinski et al. 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lewinski et al. 2006
Not checked in the free run.
- Premisecitation
Signaling through the viral enhancer is essential to reactivate latent proviruses and support virus replication in primary T-cells, whether stimulated by NF-kB or NFAT.
“Although mutation of the NF-kB sites results in only a modest inhibition of virus growth in most transformed cell lines (Chen et al. 1997), signaling through the viral enhancer is essential to reactivate latent proviruses and support virus replication in primary T-cells, regardless of whether it is stimulated by NF-kB or by NFAT (Alcami et al. 1995;Bosque and Planelles 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Alcami et al. 1995
Not checked in the free run.
- cites Bosque and Planelles 2008
Not checked in the free run.
- Interpretationreasoning
The transactivation mechanism involves phosphorylation events mediated by Tat-activated P-TEFb that modify both positive and negative cellular elongation factors.
“As described in Figure 2A, the transactivation mechanism involves a complex set of phosphorylation events mediated by the Tat-activated P-TEFb that modify both positive and negative cellular elongation factors.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Sequestration of P-TEFb in the 7SK RNP complex prevents basal transcriptional activation by Tat-independent recruitment of P-TEFb to the provirus.
“The sequestration of P-TEFb in the 7SK RNP complex effectively prevents any basal transcriptional activation by Tat-independent recruitment of P-TEFb to the provirus.”
Quote in the paperSubstantial claim - Premisecitation
In the absence of Tat, HIV-1 transcription elongation is highly restricted by the negative elongation factor NELF.
“In the absence of Tat, HIV-1 transcription elongation is highly restricted by the negative elongation factor NELF (Yamaguchi et al. 1999;Narita et al. 2003;Zhang et al. 2007).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Yamaguchi et al. 1999
Not checked in the free run.
- cites Narita et al. 2003
Not checked in the free run.
- cites Zhang et al. 2007
Not checked in the free run.
- Premisereasoning
The HIV-1 LTR is an extremely efficient promoter capable of supporting higher transcription levels than the adenovirus major late promoter or the CMV immediate early promoter.
“As a result, the HIV-1 LTR is an extremely efficient promoter that is capable of supporting even higher levels of transcription than the adenovirus major late promoter or the CMV immediate early promoter.”
Quote in the paperNot a substantial claim - Premisecitation
Tat overcomes the 7SK RNP barrier by disrupting the complex through competition with HEXIM for CycT1 binding.
“Tat overcomes this barrier by disrupting the 7SK RNP complex by competing with HEXIM for CycT1 binding (Barboric et al. 2007;Sedore et al. 2007;Krueger et al. 2010).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Barboric et al. 2007
Not checked in the free run.
- cites Sedore et al. 2007
Not checked in the free run.
- cites Krueger et al. 2010
Not checked in the free run.
- Premisecitation
Mutation of the NF-kB sites results in only modest inhibition of virus growth in most transformed cell lines.
“Although mutation of the NF-kB sites results in only a modest inhibition of virus growth in most transformed cell lines (Chen et al. 1997), signaling through the viral enhancer is essential to reactivate latent proviruses and support virus replication in primary T-cells, regardless of whether it is stimulated by NF-kB or by NFAT (Alcami et al. 1995;Bosque and Planelles 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al. 1997
Not checked in the free run.
- Premisecitation
Transcription from latent proviruses is typically restricted by high levels of HDACs, deacetylated histones, methylated histones, and DNA methylation.
“Typically, transcription from latent proviruses is restricted by high levels of histone deacetylases (HDACs), deacetylated histones, methylated histones, and DNA methylation (for reviews, see Margolis 2010; Karn 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Margolis 2010
Not checked in the free run.
- cites Karn 2011
Not checked in the free run.
- Premisecitation
Tat:P-TEFb phosphorylates the RNAP II CTD during elongation, creating a hyperphosphorylated RNA polymerase enriched for phosphorylated Ser2 residues.
“Cell-free transcription studies have shown that Tat:P-TEFb also phosphorylates the RNAP II CTD during elongation (Isel and Karn 1999;Kim et al. 2002).This reaction creates a hyperphosphorylated form of the RNA polymerase that is highly enriched for phosphorylated Ser2 residues in the CTD (Ramanathan et al. 2001;Kim et al. 2002).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Isel and Karn 1999
Not checked in the free run.
- cites Kim et al. 2002
Not checked in the free run.
- cites Ramanathan et al. 2001
Not checked in the free run.
- Premisecitation
In actively replicating cells such as HeLa and Jurkat T-cells, P-TEFb activity is tightly regulated and most of the enzyme is sequestered in an inactive 7SK RNP complex comprising 7SK RNA and RNA-binding proteins.
“In actively replicating cells, such as HeLa cells and Jurkat T-cells, P-TEFb activity is tightly regulated and the majority of the enzyme is sequestered into a large inactive 7SK RNP complex comprising 7SK RNA and a series of RNA-binding proteins (Fig. 2B) (Nguyen et al. 2001;Yang et al. 2001).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Nguyen et al. 2001
Not checked in the free run.
- cites Yang et al. 2001
Not checked in the free run.
- Premisecitation
Because NF-kB and NFAT recognition sequences overlap, their binding to the HIV-1 motifs is mutually exclusive.
“Because their recognition sequences overlap, binding of these factors is mutually exclusive (Chen-Park et al. 2002;Giffin et al. 2003).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Chen-Park et al. 2002
Not checked in the free run.
- cites Giffin et al. 2003
Not checked in the free run.
- Interpretationreasoning
Activation of P-TEFb in primary resting central memory T-cells and monocytes requires multiple steps involving initial assembly of the 7SK RNP complex and its relocalization to nuclear speckles where it becomes accessible to Tat and the transcription machinery.
“Activation of P-TEFb in these cells therefore requires multiple steps involving both the initial assembly of the 7SK RNP complex and its relocalization to nuclear speckles where it becomes accessible to Tat and the rest of the transcription machinery.”
Quote in the paperSubstantial claim - Interpretationreasoning
Any model for the stimulatory effects of P-TEFb on HIV-1 transcription must account for ELL2 and possibly additional elongation factors.
“Thus, any model for the stimulatory effects of P-TEFb on HIV-1 transcription now has to take into account the role of ELL2 and possibly several additional elongation factors.”
Quote in the paperSubstantial claim - Premisecitation
Binding of NF-kB to the HIV-1 motifs is more efficient than NFAT because it is enhanced by cooperative interactions with Sp1.
“Binding of NF-kB is more efficient than NFAT because it is enhanced by cooperative interactions with Sp1 (Perkins et al. 1993).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Perkins et al. 1993
Not checked in the free run.
- Premisecitation
HIV-1 relies on an enhancer region containing two NF-kB binding motifs.
“In addition to the core promoter, HIV-1 relies on an “enhancer region” that contains two NF-kB binding motifs (Nabel and Baltimore 1987) (see online Movie 2 at www.per spectivesinmedicine.org).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nabel and Baltimore 1987
Not checked in the free run.
- Premisecitation
Stochastic fluctuations in Tat gene expression can act as a molecular switch.
“Insightful studies by Weinberger et al. (Weinberger et al. 2005;Weinberger and Shenk 2006) and Burnett et al. (2009) have emphasized how stochastic fluctuations in Tat gene expression can act as a molecular switch.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Weinberger et al. 2005
Not checked in the free run.
- cites Weinberger and Shenk 2006
Not checked in the free run.
- cites Burnett et al. 2009
Not checked in the free run.
- Premisecitation
Each core promoter element participates in cooperative binding of the initiation factor TFIID and its associated TAF cofactors to the TATA element.
“Each of these elements participates in the cooperative binding of the initiation factor TFIID and its associated TAF cofactors to the TATA element (Rittner et al. 1995).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rittner et al. 1995
Not checked in the free run.
- Premisecitation
Proteomic studies identified large protein complexes containing Tat, P-TEFb, and the human transcription factors/coactivators AFF4, ENL, AF9, and ELL2.
“Our picture of how Tat and P-TEFb stimulate HIV-1 elongation has recently been refined by two proteomic studies that identified large protein complexes containing Tat P-TEFb and the human transcription factors/coactivators AFF4, ENL, AF9, and ELL2 (Fig. 2B) (He et al. 2010;Sobhian et al. 2010).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites He et al. 2010
Not checked in the free run.
- cites Sobhian et al. 2010
Not checked in the free run.
- Premisecitation
P-TEFb phosphorylates Spt5, a subunit of DSIF that carries a CTD homologous to the RNAP II CTD.
“In addition to targeting RNAP II, P-TEFb is also able to extensively phosphorylate Spt5, a subunit of the DRB sensitivityinducing factor (DSIF), which carries a CTD homologous to the RNAP II CTD (Ivanov et al. 2000;Bourgeois et al. 2002).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Ivanov et al. 2000
Not checked in the free run.
- cites Bourgeois et al. 2002
Not checked in the free run.
- Premisereasoning
HIV-1 and many other retroviruses, including HTLV-1 and HTLV-II, express regulatory factors that facilitate transport of intron-containing viral RNA out of the nucleus.
“To circumvent these surveillance mechanisms, HIV-1 and many other retroviruses, including the human T-cell leukemia viruses HTLV-1 and HTLV-II, express regulatory factors that facilitate the transport of intron-containing viral RNA out of the nucleus.”
Quote in the paperSubstantial claim - Premisenone given
A few HIV-1 mRNA isoforms are produced by inclusion of exons flanked by 3' splice site A1 and 5' splice site D2 (exon 2) and/or the exon flanked by 3' splice site A2 and 5' splice site D3 (exon 3).
“Adding to the complexity of the mRNA species present in infected cells, a few viral mRNA isoforms are also produced by inclusion of exons flanked by 3 0 ss A1 and 5 0 ss D2 (exon 2) and/or the exon flanked by 3 0 ss A2 and 5 0 ss D3 (exon 3).”
Quote in the paperNot a substantial claim - Premisecitation
This RNA helix change lets the Rev arginine-rich domain enter the major groove.
“This change in the structure of the RNA helix allows binding of the Rev ARD to the major groove (Battiste et al. 1996;Daugherty et al. 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Battiste et al. 1996
Not checked in the free run.
- cites Daugherty et al. 2008
Not checked in the free run.
- Premisereasoning
All HIV-1 mRNAs include the highly structured noncoding exon 1 extending from the 5' cap to 5' splice site D1.
“As a result, all HIV-1 mRNAs include the highly structured noncoding exon 1 that extends from the 5 0 cap to 5 0 ss D1.”
Quote in the paperNot a substantial claim - Premisereasoning
The 9-kb and 4-kb HIV-1 transcripts that encode Gag, Pol, and Env depend on Rev for export and expression.
“Initial studies showed that the 9-kb and 4-kb HIV-1 mRNA species, which encode the structural proteins Gag, Pol, and Env, require Rev for their transport and expression.”
Quote in the paperSubstantial claim - Premisenone given
Control of HIV-1 splicing involves exonic splicing enhancers and intronic splicing enhancers that facilitate splice site recognition and are selectively bound by SR proteins.
“Control of splicing in HIV-1 involves exonic splicing enhancers (ESEs) and intronic splicing enhancers (ISEs) which facilitate splice site recognition and are selectively bound by members of the SR (Ser-Arg) protein family.”
Quote in the paperNot a substantial claim - Premisecitation
Formation of HIV-1 splicing complexes is affected by the strengths of various downstream 5' splice sites, an expected consequence of exon definition.
“Formation of HIV-1 splicing complexes is also affected by the strengths of the various downstream 5 0 ss-an expected consequence of exon definition (Robberson et al. 1990;Hoffman and Grabowski 1992).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Robberson et al. 1990
Not checked in the free run.
- cites Hoffman and Grabowski 1992
Not checked in the free run.
- Interpretationreasoning
The distinct export requirements result from removal of the env segment spanning splice sites D4 and A7, including the RRE, during complete splicing.
“This division of transport mechanisms is achieved because the region of the HIV-1 env gene between 5 0 ss D4 and 3 0 ss A7 that contains the RRE is removed in the completely spliced mRNAs (Figs. 3 and 4).”
Quote in the paperSubstantial claim - Premisenone given
Rev-dependent export requires Rev to bind the RRE.
“Rev-regulated transport requires Rev binding to the RRE.”
Quote in the paperSubstantial claim - Premisecitation
HIV-1 Rev interacts with a highly structured RNA element in the env gene called the Rev-responsive element (RRE).
“The first of these factors to be discovered was the HIV-1 Rev protein which interacts with a highly structure RNA element in the env gene referred to as the Rev-responsive element (RRE) (Sodroski et al. 1986;Malim et al. 1989).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Sodroski et al. 1986
Not checked in the free run.
- cites Malim et al. 1989
Not checked in the free run.
- Premisereasoning
The fully spliced 1.8-kb HIV-1 transcripts encoding Tat, Rev, and Nef leave the nucleus without Rev via a cellular export route used by host mRNAs.
“On the other hand, the completely spliced 1.8-kb mRNAs, which encode Tat, Rev, and Nef, are exported to the cytoplasm in the absence of Rev by an endogenous cellular pathway used by cellular mRNAs.”
Quote in the paperSubstantial claim - Premisecitation
Analysis of HIV-1 mRNA species in virus-infected cells showed striking differences in the relative abundances of different viral mRNA species.
“Analysis of HIV-1 mRNA species in virusinfected cells showed that there are striking differences in the relative abundances of the different viral mRNA species (Purcell and Martin 1993).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Purcell and Martin 1993
Not checked in the free run.
- Interpretationreasoning
Maximum HIV-1 replication requires tight regulation of splicing to balance mRNA and genome RNA production.
“The dramatic effects of these splicing element mutations show that maximum virus replication requires tight regulation of splicing to balance mRNA and genome RNA production.”
Quote in the paperSubstantial claim - Premisecitation
Splicing at the relatively weak 3' splice site A1, required for high vif mRNA expression and inclusion of noncoding exon 2, is facilitated by several ESEs within exon 2.
“Splicing at the relatively weak 3 0 ss A1, which is required for high vif mRNA expression and inclusion of the noncoding exon 2, is facilitated by several different ESEs (ESE-Vif, ESE M1, and ESE M2) within exon 2 (Kammler et al. 2006;Exline et al. 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kammler et al. 2006
Not checked in the free run.
- cites Exline et al. 2008
Not checked in the free run.
- Premisecitation
GAR ESE activity raises levels of incompletely spliced env/vpu mRNAs and completely spliced nef and rev mRNAs to the point that they become the most abundant spliced mRNA species in the HIV-1-infected cell.
“GAR ESE activity is able to raise the levels of incompletely spliced env/vpu mRNAs and completely spliced nef and rev mRNAs to the point that they become the most abundant spliced mRNA species in the HIV-1-infected cell (Purcell and Martin 1993).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Purcell and Martin 1993
Not checked in the free run.
- Premisenone given
Splicing at the weak 3' splice sites A4c, A4a, A4b, and A5 is greatly facilitated by a guanosine-adenosine-rich ESE, GAR, within exon 5.
“By contrast, splicing at the weak 3 0 ss A4c, A4a, A4b, and A5 sites is greatly facilitated by a guanosine-adenosine-rich ESE (GAR) within exon 5.”
Quote in the paperSubstantial claim - Premisereasoning
HIV-1 primary transcripts undergo extensive and complex alternative splicing in the nucleus of infected cells.
“To produce the full range of mRNAs needed to encode the viral proteins, HIV-1 primary transcripts undergo extensive and complex alternative splicing in the nucleus of infected cells (Fig. 3).”
Quote in the paperSubstantial claim - Premisecitation
The excessive splicing phenotype caused by ESSV mutation resulted in decreased virus replication.
“This excessive splicing phenotype resulted in a decrease in virus replication (Madsen and Stoltzfus 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Madsen and Stoltzfus 2005
Not checked in the free run.
- Premisecitation
Small changes in initiation rates, mimicked by mutations in NF-kB and Sp1 binding sites, reduce Tat availability and disproportionately limit HIV-1 transcription, forcing viruses into latency.
“Small changes in initiation rates, which can be experimentally mimicked by introducing mutations into the NF-kB and Sp1 binding sites, are able to reduce Tat availability and disproportionately limit HIV-1 transcription, forcing viruses into latency (Burnett et al. 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Burnett et al. 2009
Not checked in the free run.
- Interpretationreasoning
Because of reduced Vif levels, replication of virus mutants with decreased U1 snRNP affinity exhibits greater sensitivity than wild-type virus to inhibition by APOBEC3G.
“Because of reduced levels of Vif, the replication of these virus mutants exhibit greater sensitivity than wild-type virus to inhibition by the cellular restriction factor APOBEC3G.”
Quote in the paperSubstantial claim - Premisecitation
Several other retroviruses, as originally shown for Mason-Pfizer monkey virus, dispense with a protein factor and encode cis elements called constitutive transport elements that directly interact with cellular RNA export factors.
“Several other retroviruses, as originally shown for Mason-Pfizer monkey virus (MPMV), dispense with a protein factor and simply encode cis elements, referred to as constitutive transport elements or CTEs, that directly interact with cellular RNA export factors (for reviews of HIV-1 and MPMV RNA export, see Pollard and Malim 1998;Cullen 2003).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Pollard and Malim 1998
Not checked in the free run.
- cites Cullen 2003
Not checked in the free run.
- Premisecitation
Splicing at 3' splice site A2 is repressed by an ESS element within exon 3, ESSV, resulting in relatively low levels of vpr mRNA.
“Similarly, splicing at 3 0 ss A2 is repressed by an ESS element within exon 3 (ESSV), which results in relatively low levels of vpr mRNA (Bilodeau et al. 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bilodeau et al. 2001
Not checked in the free run.
- Interpretationreasoning
HIV-1 remains poised to resume replication in response to triggers that stimulate transcription initiation and restore Tat levels.
“However, the virus remains poised to resume its replication in response to triggers that stimulate transcription initiation and restore Tat levels.”
Quote in the paperSubstantial claim - Premisenone given
In each spliced HIV-1 mRNA, the 5' splice site D1 is spliced to one of the 3' splice sites.
“In each of the spliced mRNAs, the 5 0 ss D1 (sometimes referred to as the “major splice donor”) is spliced to one of the 3 0 ss.”
Quote in the paperNot a substantial claim - Premisecitation
Rev binding at the high-affinity RRE site triggers a conformational change that creates two purine-purine non-Watson-Crick base pairs.
“NMR studies have shown that, as in the case of the Tat-TAR interaction, the Rev binding to the high affinity site induces a conformational change that results in the formation of two purine-purine non-Watson-Crick base pairs (Fig. 5A).”
Quote in the paperNot a substantial claim - Premisecitation
HIV-1 3' splice sites are generally relatively inefficient compared to constitutive cellular 3' splice sites.
“In general, HIV-1 3 0 splice sites are relatively inefficient in comparison to constitutive cellular 3 0 splice sites (for reviews of HIV-1 splicing, see Stoltzfus and Madsen 2006;Stoltzfus 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Stoltzfus and Madsen 2006
Not checked in the free run.
- cites Stoltzfus 2009
Not checked in the free run.
- Premisenone given
Most HIV-1 strains use four different 5' splice sites and eight different 3' splice sites to produce more than 40 different spliced mRNA species in infected cells.
“Most HIV-1 strains use four different splice donor or 5 0 splice sites (5 0 ss) and eight different acceptor or 3 0 splice sites (3 0 ss) to produce more than 40 different spliced mRNA species in infected cells.”
Quote in the paperNot a substantial claim - Premisecitation
Rev first attaches to a high-affinity site at the RRE apex, stem IIB.
“Rev binds initially to a high affinity site located near the apex of the RRE structure (stem IIB) (Daly et al. 1989;Heaphy et al. 1990).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Daly et al. 1989
Not checked in the free run.
- cites Heaphy et al. 1990
Not checked in the free run.
- Premisecitation
The RRE is a 351-nucleotide elongated stem-loop.
“The RRE is an elongated stemloop structure of 351 nt (Malim et al. 1989;Mann et al. 1994;Watts et al. 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Malim et al. 1989
Not checked in the free run.
- cites Mann et al. 1994
Not checked in the free run.
- cites Watts et al. 2009
Not checked in the free run.
- Premisecitation
After the initial high-affinity RRE contact, more Rev monomers join the complex.
“Binding of Rev to the high affinity RRE site is then followed by binding of additional monomers to the complex (Malim and Cullen 1991;Zapp et al. 1991;Mann et al. 1994).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Malim and Cullen 1991
Not checked in the free run.
- cites Zapp et al. 1991
Not checked in the free run.
- cites Mann et al. 1994
Not checked in the free run.
- Premisecitation
The HIV-1 U3 sequence upstream of the 3' processing signal, but not linked to the 5' processing signal, has upstream enhancer elements that help CPSF bind and increase 3'-end polyadenylation.
“First, the HIV-1 U3 sequence, which is upstream of the 3 0 processing signal, but not associated with the 5 0 processing signal, contains upstream enhancer elements (USE) that act to facilitate binding of CPSF and enhance polyadenylation at the 3 0 end of the HIV-1 transcripts (Gilmartin et al. 1995).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gilmartin et al. 1995
Not checked in the free run.
- Interpretationcitation
Which export route is used strongly affects the cytoplasmic fate of unspliced HIV-1 RNA.
“In contrast to cellular mRNAs, the cytoplasmic fate of unspliced HIV-1 RNA appears to be strongly influenced by the choice of RNA export pathway.”
Quote in the paperSubstantial claim - Premisecitation
Factors that bind upstream of the AAUAAA site are thought to open the poly(A) hairpin and favor use of the 3' LTR poly(A) site.
“Factors binding to sequences upstream of the AAUAAA site are believed to open up the poly(A) hairpin and allow preferential use of the 3 0 LTR poly(A) processing site (Das et al. 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Das et al. 1999
Not checked in the free run.
- Interpretationreasoning
HIV-1 directs processing to the 3' LTR cleavage site using multiple regulatory elements.
“HIV-1 uses multiple regulatory elements to direct processing to the 3 0 LTR cleavage site.”
Quote in the paperSubstantial claim - Premisenone given
HIV-1 carries two copies of AAUAAA and GU-rich core elements at the R sequence ends in both LTRs.
“Like most retroviruses, HIV-1 contains a duplicated set of AAUAAA and GU-rich core elements at the ends of the R sequences found in both the 5 0 and 3 0 LTRs.”
Quote in the paperNot a substantial claim - Premisecitation
With excess Rev, a defined RNP complex containing three dimers bound to the RRE forms.
“When excess Rev is present, a defined RNP complex of three dimers bound to the RRE is formed (Fig. 5C) (Daugherty et al. 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Daugherty et al. 2010
Not checked in the free run.
- Premisecitation
Mutations in 5'ss D1 that reduce U1 snRNP binding allow use of the normally silent 5' LTR poly(A) site.
“Mutations of 5 0 ss D1 that weaken binding of U1 snRNP allow the usage of the normally silent 5 0 LTR poly(A) site (Ashe et al. 1995(Ashe et al. , 2000)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ashe et al. 1995
Not checked in the free run.
- cites Ashe et al. 2000
Not checked in the free run.
- Premisecitation
HIV-1 RNA exits the nucleus through nuclear pore complexes.
“Transport of HIV-1 RNA out of the nucleus, as with most cellular proteins and RNAs, occurs via the nuclear pore complexes (NPC) (Fig. 5D) (for review see Kohler and Hurt 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kohler and Hurt 2007
Not checked in the free run.
- Premisecitation
CRS/INS elements placed in heterologous constructs give Rev regulation to RNAs made from those constructs.
“These elements can be introduced into heterologous expression constructs and confer Rev-regulation to RNAs produced from these constructs (Schwartz et al. 1992;Najera et al. 1999).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Schwartz et al. 1992
Not checked in the free run.
- cites Najera et al. 1999
Not checked in the free run.
- Interpretationreasoning
A second protein-protein interface enables Rev oligomers to serve as an adaptor to the export machinery, with RNA on one side and Crm1 on the other.
“A second protein -protein interface permits Rev oligomers to act as an adaptor to the host export machinery, with viral RNA bound to one face and Crm1 to another.”
Quote in the paperSubstantial claim - Premisenone given
Some HIV-1 mRNA UTRs have AUGs upstream of the true initiator AUG that can interfere with initiation at the true AUG.
“Furthermore, some of the HIV-1 mRNA UTRs contain AUG sequences upstream of the authentic initiator AUG that can interfere with translation initiation at the authentic AUG.”
Quote in the paperNot a substantial claim - Premisecitation
Rev returns to the nucleus by binding importin-b.
“Rev then reenters the nucleus by binding to the nuclear import factor, importin-b (Henderson and Percipalle 1997).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Henderson and Percipalle 1997
Not checked in the free run.
- Interpretationreasoning
Because HIV-1 exon 1 has several structured elements-TAR, the primer-binding site, the poly(A) hairpin, and packaging signals-ordinary ribosomal scanning for initiation is blocked.
“Because the HIV-1 exon 1 contains multiple highly structured regions including the TAR sequence, the primer binding site, the poly(A) hairpin, and RNA packaging sequences, a typical ribosomal scanning mechanism for translational initiation is precluded.”
Quote in the paperSubstantial claim - Premisenone given
RRE-bound Rev contacts Crm1 via a 10-residue leucine-rich nuclear export signal near its carboxyl terminus.
“Rev bound to the RRE interacts with the karyopherin family member Crm1 (also referred to as exportin 1) through an 10 amino acid leucine-rich export nuclear export signal (NES) near the Rev carboxyl terminus.”
Quote in the paperNot a substantial claim - Premisecitation
U1 snRNP inhibits the 5' LTR 3' processing and poly(A) site by binding adjacent 5'ss D1.
“Finally, the splicing factor U1 snRNP acts to inhibit the 3 0 processing and poly(A) site in the 5 0 LTR by binding to the adjacent 5 0 ss D1.”
Quote in the paperNot a substantial claim - Premisenone given
The 5' and 3' LTR poly(A) processing sites are embedded in a poly(A) hairpin in exon 1 just downstream of TAR.
“Second, the 5 0 and 3 0 LTR poly(A) processing sites are imbedded in a region of secondary structure called the poly(A) hairpin located in exon 1 immediately downstream from the TAR hairpin structure.”
Quote in the paperNot a substantial claim - Premisecitation
In human cells, HIV-1 assembly is defective when gag-pol mRNA export relies on the hepatitis B posttranscriptional element.
“Similarly, defective HIV-1 assembly occurred in human cells when export of gag-pol mRNA is dependent on the presence of the hepatitis B posttranscriptional element (PRE) (Jin et al. 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jin et al. 2009
Not checked in the free run.
- Interpretationnone given
Rev regulation depends on accumulation of a nuclear pool of unspliced and incompletely spliced mRNAs.
“Rev regulation requires accumulation of a pool of unspliced and incompletely spliced mRNAs in the nucleus.”
Quote in the paperSubstantial claim - Premisecitation
Several cellular RNA-binding proteins, including PABP1, hnRNP A1, and the PSF/p54(nrb) heterodimer, have been linked to CRS/INS-mediated retention.
“A number of different cellular RNA-binding proteins have been implicated in the retention mediated by CRS/INS elements including poly(A)-binding protein 1 (PABP1), heterogeneous ribonuclear protein A1 (hnRNP A1), and the heterodimer of two related proteins polypyrimidine tract binding proteinassociated splicing factor (PSF) and p54(nrb) (Black et al. 1996;Afonina et al. 1997;Najera et al. 1999;Zol”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Black et al. 1996
Not checked in the free run.
- cites Afonina et al. 1997
Not checked in the free run.
- cites Najera et al. 1999
Not checked in the free run.
- Premisecitation
In the Rev dimer, the arginine-rich RNA-binding helices sit at the ends of a V-shaped assembly.
“In the Rev dimer, the arginine-rich RNAbinding helices are located at the ends of a V-shaped assembly.”
Quote in the paperNot a substantial claim - Premisecitation
After nuclear export, RanGAP and RanBP1 promote hydrolysis of bound GTP to GDP.
“After export to the cytoplasm through the NPC, the bound GTP is hydrolyzed to GDP facilitated by the proteins RanGAP (Ran GTPase-activating protein) and RanBP1.”
Quote in the paperNot a substantial claim - Premisecitation
A USE element near the 5' end of Nef binds SR protein 9G8, which recruits CF1m and CPSF.
“Another USE element near the 5 0 end of the Nef gene binds the cellular SR protein 9G8 which recruits the 3 0 processing factor CF1m and CPSF (Valente et al. 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Valente et al. 2009
Not checked in the free run.
- Premisecitation
One mechanism that skips the vpu ORF and allows efficient translation at the downstream env AUG is 5' cap-dependent ribosome shunting.
“An additional mechanism, which is used to bypass the vpu open reading frame and permit efficient translation at the downstream env AUG, involves 5 0 cap-dependent ribosome shunting in which the scanning ribosome jumps over large regions of the mRNA before recognizing the correct initiation codon (Krummheuer et al. 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Krummheuer et al. 2007
Not checked in the free run.
- Premisecitation
Pausing by itself seems insufficient for frameshifting, since other translation roadblocks do not support it.
“Pausing alone appears to be insufficient for frameshifting because addition of other roadblocks to translation are unable to support frameshifting (Brierley and Dos Ramos 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brierley and Dos Ramos 2006
Not checked in the free run.
- Premisenone given
HIV-1 and other retroviruses have posttranscriptional elements that bind cellular RNA-binding proteins and can enhance translation initiation.
“Additionally, HIV-1 and other retroviruses contain posttranscriptional elements (PCEs) that bind to cellular RNA binding proteins that can act as enhancers to facilitate translation initiation.”
Quote in the paperNot a substantial claim - Interpretationnone given
The actions of Tat and Rev, unprecedented when discovered, have revealed previously unknown and unexpected features of transcription elongation, splicing, and RNA export.
“The mechanisms of action of both proteins, which were unprecedented at the time of their discovery, have now illuminated features of transcription elongation control, RNA splicing, and RNA export that were entirely unknown and unexpected.”
Quote in the paperSubstantial claim - Premisenone given
Two essential cis-acting elements 200 nt upstream of the Gag stop codon are needed for HIV-1 frameshifting.
“Two essential cis-acting sequence elements located 200 nt upstream of the Gag termination codon are required for frameshifting.”
Quote in the paperSubstantial claim - Interpretationreasoning
HIV-1 gene expression is governed by Tat and Rev, RNA-binding proteins that coordinate interactions with host transcription, splicing, and RNA transport machinery.
“As summarized above, gene expression in HIV-1 is controlled by the RNA-binding proteins Tat and Rev, which orchestrate complex interactions with the cellular transcription, RNA splicing, and RNA transport machinery.”
Quote in the paperSubstantial claim - Premisecitation
HIV-1, like all retroviruses, uses programmed frameshifting, in which mRNA sequence and structure signals specify a reading-frame change during translation.
“In common with all other retroviruses, HIV-1 has evolved a novel mechanism of programmed frameshifting in which specific sequence and structural signals in the mRNA can specify an mRNA reading frame change during translation (for review, see Brierley and Dos Ramos 2006;Bolinger and Boris-Lawrie 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Brierley and Dos Ramos 2006
Not checked in the free run.
- cites Bolinger and Boris-Lawrie 2009
Not checked in the free run.
- Premisenone given
In HIV-1, a -1 reading-frame shift is needed to move from Gag to the pro and pol frame.
“In HIV-1, a 21 shift in the translational reading frame is required to shift from the Gag reading frame to the pro and pol reading frame.”
Quote in the paperNot a substantial claim - Premisecitation
A growing set of host nuclear RNA-binding proteins bind HIV-1 RNA or Rev and may affect export and cytoplasmic use.
“In addition, there have been a growing number of host cell nuclear RNA binding proteins identified that bind to HIV-1 RNA or to Rev and may influence its export and cytoplasmic utilization (for reviews, see Cochrane et al. 2006;Cochrane 2009;Suhasini and Reddy 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Cochrane et al. 2006
Not checked in the free run.
- cites Cochrane 2009
Not checked in the free run.
- cites Suhasini and Reddy 2009
Not checked in the free run.
- Premisecitation
The export route taken by HIV-1 RNA influences viral assembly at the plasma membrane.
“Remarkably, the export pathway used by the RNA affects viral assembly at the plasma membrane (Jin et al. 2009;Sherer et al. 2009), suggesting the site of translation influences subsequent protein function.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Jin et al. 2009
Not checked in the free run.
- cites Sherer et al. 2009
Not checked in the free run.
- Interpretationreasoning
The location of translation affects later protein function.
“suggesting the site of translation influences subsequent protein function.”
Quote in the paperSubstantial claim
- May combine two claims. 47
- Classified as probably not a substantial claim. 10
May combine two claims.
PremisecitationIntroducing Y261 into human CycT1 blocks HIV-1 transactivation, while introducing C261 into murine CycT1 restores Tat-mediated transactivation.
“Introduction of Y261 into the human CycT1 blocked HIV-1 transactivation in transfected cells whereas introduction of C261 into the murine CycT1 restored Tat-mediated transactivation (Bieniasz et al. 1998;Fujinaga et al. 1998;Garber et al. 1998;Kwak et al. 1999).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Bieniasz et al. 1998
Not checked in the free run.
- cites Fujinaga et al. 1998
Not checked in the free run.
- cites Garber et al. 1998
Not checked in the free run.
May combine two claims.
PremisecitationThe TAR RNA sequence forms a highly stable, nuclease-resistant stem-loop structure, and mutations that destabilize this structure abolish Tat-stimulated transcription.
“Genetic evidence that TAR functions as a transcribed RNA regulatory signal came from the observation that the TAR RNA sequence forms a highly stable, nuclease-resistant, stem-loop structure; mutations that destabilize the TAR RNA structure abolish Tat-stimulated transcription (Berkhout et al. 1989;Selby et al. 1989).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Berkhout et al. 1989
Not checked in the free run.
- cites Selby et al. 1989
Not checked in the free run.
May combine two claims.
PremisecitationThe crystal structure of a Tat:P-TEFb complex shows that Tat forms extensive contacts with the CycT1 subunit and with the T-loop of CDK9.
“The structure showsthat Tat forms extensive contacts both with the CycT1 subunit of P-TEFb and also with the T-loop of the Cdk9 subunit (Fig. 1C).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tahirov et al. 2010
Not checked in the free run.
May combine two claims.
PremisecitationThe kinase subunit of TAK is CDK9, a component of the positive elongation factor P-TEFb.
“Subsequently, Zhu et al. (1997) cloned the kinase subunit of TAK.This turned out to be the CDK9 kinase, which is a component of a ubiquitous positive acting elongation factor pTEFb (Marshall and Price 1995;Marshall et al. 1996).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Zhu et al. (1997)
Not checked in the free run.
- cites Marshall and Price 1995
Not checked in the free run.
- cites Marshall et al. 1996
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenIn HIV-1, as in all retroviruses, the LTR acts as the viral promoter.
“In HIV-1, as in all retroviruses, the LTR acts as the viral promoter.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationP-TEFb contains the cyclin component CycT1, which can form a stable complex with CDK9, Tat, and TAR RNA.
“Wei et al. (1998) discovered that P-TEFb contains a cyclin component, CycT1, which can form a stable complex with CDK9, Tat, and TAR RNA (see online Movie 1 at www.perspectivesinmedicine. org).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wei et al. (1998)
Not checked in the free run.
May combine two claims.
PremisecitationFull-length unspliced HIV-1 transcripts synthesized late act as virion genomic RNA and as mRNA for the Gag-Pol polyprotein.
“Also synthesized late are the full-length unspliced transcripts which act both as the virion genomic RNA and the mRNA for the Gag-Pol polyprotein (Kim et al. 1989;Pomerantz et al. 1990).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Kim et al. 1989
Not checked in the free run.
- cites Pomerantz et al. 1990
Not checked in the free run.
May combine two claims.
PremisecitationTAR is only functional when placed 3' to the HIV-1 promoter and in the correct orientation and position.
“It quickly became apparent that TAR was not a typical transcription element, because it is only functional when it is placed 3 0 to the HIV-1 promoter, and in the correct orientation and position (Muesing The amino-terminal “activation” domain of Tat binds to the CDK9 T-loop, a region of the molecule that is essential for its enzymatic activity (Tahirov et al. 2010).et al. 1987).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Muesing et al. 1987
Not checked in the free run.
May combine two claims.
Premisenone givenAs infection proceeds, HIV-1 transcription increases sharply and larger incompletely spliced mRNAs are produced.
“As the infection proceeds, transcription increases sharply, and larger, incompletely spliced mRNAs are produced.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTat specifically recognizes TAR RNA, with its recognition site mapped to a U-rich bulge near the apex of the TAR RNA stem.
“Dingwall et al. (1989Dingwall et al. ( , 1990) ) showed that Tat is able to specifically recognize TAR RNA and mapped its recognition site to a U-rich bulge near the apex of the TAR RNA stem (Fig. 1B).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dingwall et al. (1989, 1990)
Not checked in the free run.
May combine two claims.
PremisecitationIn the absence of Tat, most RNA polymerases initiating HIV-1 transcription stall near the promoter, whereas in the presence of Tat the density of RNA polymerases downstream from the promoter increases dramatically.
“They showed that in the ab-sence of Tat, the majority of RNA polymerases initiating transcription stall near the promoter, whereas in the presence of Tat, there is a dramatic increase in the density of RNA polymerases found downstream from the promoter.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kao et al. (1987)
Not checked in the free run.
May combine two claims.
PremisecitationUnmodified DSIF inhibits elongation, while phosphorylation of Spt5 separates it from the complex and converts it into a positive elongation factor that stabilizes transcription complexes at terminator sequences.
“Although the unmodified DSIF inhibits elongation (Yamaguchi et al. 2002), phosphorylation of Spt5 separates it from the rest of the complex and converts it into a positive elongation factor that stabilizes transcription complexes at terminator sequences (Bourgeois et al. 2002;Yamada et al. 2006).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Yamaguchi et al. 2002
Not checked in the free run.
- cites Bourgeois et al. 2002
Not checked in the free run.
- cites Yamada et al. 2006
Not checked in the free run.
May combine two claims.
PremisecitationEssential components of the 7SK RNP complex include HEXIM1 or HEXIM2, which inhibit CDK9 in a 7SK-dependent manner, and the 7SK RNA binding proteins LARP-7 and BCDIN3.
“Essential components of the 7SK RNP complex include HEXIM1 or HEXIM2, which inhibit the CDK9 kinase in a 7SK-dependent manner (Yik et al. 2003;Michels et al. 2004), and the 7SK RNA binding proteins LARP-7 (He et al. 2008;Krueger et al. 2008), and BCDIN3 (Jeronimo et al. 2007).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Yik et al. 2003
Not checked in the free run.
- cites Michels et al. 2004
Not checked in the free run.
- cites He et al. 2008
Not checked in the free run.
May combine two claims.
PremisecitationMembers of the NF-kB family and NFAT can bind to the HIV-1 NF-kB motifs.
“Members of both the NF-kB family (Liu et al. 1992) and NFAT (Kinoshita et al. 1998) can bind to the HIV-1 NF-kB motifs.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Liu et al. 1992
Not checked in the free run.
- cites Kinoshita et al. 1998
Not checked in the free run.
May combine two claims.
InterpretationreasoningTat and P-TEFb stimulate HIV-1 transcription by removing elongation blocks imposed by NELF and DSIF and by enhancing RNAP II processivity through phosphorylation of Spt5 and the RNAP II CTD.
“Thus, Tat and P-TEFb are able to stimulate HIV-1 transcription both through the removal of blocks to elongation imposed by NELF and DSIF and by the enhancement of RNAP II processivity through the phosphorylation of Spt5 and the RNAP II CTD.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPhosphorylation of NELF-E by P-TEFb causes dissociation of NELF from TAR and releases paused transcription elongation complexes.
“Transcription of the HIV provirus dissociation of NELF from TAR and releases paused transcription elongation complexes (Fujinaga et al. 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fujinaga et al. 2004
Not checked in the free run.
May combine two claims.
InterpretationcitationNucleosomal structures play a crucial role in establishing HIV-1 latency because epigenetic modifications of the provirus restrict transcription initiation.
“These nucleosomal structures play a crucial role in establishing HIV-1 latency because epigenetic modifications of the provirus restrict transcription initiation (see Siliciano and Greene 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Siliciano and Greene 2011
Not checked in the free run.
May combine two claims.
InterpretationcitationConditions that restrict transcription initiation reduce Tat levels below threshold, causing dramatically reduced HIV-1 transcription and eventually latency.
“Because Tat functions as part of a positive regulatory circuit, conditions that restrict transcription initiation will in turn cause a reduction in Tat levels to below threshold levels and therefore result in dramatically reduced HIV-1 transcription and eventually entry into latency (for reviews, see Karn 2011;Siliciano and Greene 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Karn 2011
Not checked in the free run.
- cites Siliciano and Greene 2011
Not checked in the free run.
May combine two claims.
PremisecitationELL2 is critical for basal HIV-1 transcription and Tat-mediated transactivation.
“One of these coactivators, ELL2, an elongation factor, which was previously shown to enhance transcription elongation by preventing RNAP II backtracking, is critical both for basal HIV-1 transcription and Tat-mediated transactivation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe HIV-1 core promoter is powerful and highly optimized, comprising three tandem SP1 binding sites, an efficient TATA element, and a highly active initiator sequence.
“The core promoter is a powerful and highly optimized promoter comprised of three tandem SP1 binding sites (Jones et al. 1986), an efficient TATA element (Garcia et al. 1989), and a highly active initiator sequence (Zenzie-Gregory et al. 1993).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Jones et al. 1986
Not checked in the free run.
- cites Garcia et al. 1989
Not checked in the free run.
- cites Zenzie-Gregory et al. 1993
Not checked in the free run.
May combine two claims.
PremisecitationPrimary resting central memory T-cells and primary monocytes show highly restricted levels of CycT1.
“In contrast to Jurkat T-cells both primary resting central memory T-cells (Ramakrishnan et al. 2009) and primary monocytes (Sung and Rice 2009) show highly restricted levels of CycT1.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Ramakrishnan et al. 2009
Not checked in the free run.
- cites Sung and Rice 2009
Not checked in the free run.
May combine two claims.
PremisecitationCyclin T1 acetylation triggers dissociation of HEXIM1 and 7SK RNA from the inactive 7SK snRNP complex and activates P-TEFb transcriptional activity.
“A recent study suggests that cyclin T1 acetylation also triggers dissociation of HEXIM1 and 7SK RNA from the inactive 7SK snRNP complex and activates the transcriptional activity of P-TEFb (Cho et al. 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cho et al. 2009
Not checked in the free run.
May combine two claims.
InterpretationcitationNELF-E can bind directly to TAR RNA, suggesting that NELF may be recruited to the HIV-1 provirus through TAR.
“Significantly, the NELF-E subunit is able to bind directly to TAR RNA (Yamaguchi et al. 2002;Fujinaga et al. 2004) suggesting that NELF might be recruited to the HIV-1 provirus via its interactions with TAR.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Yamaguchi et al. 2002
Not checked in the free run.
- cites Fujinaga et al. 2004
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenIntronic and exonic splicing silencers repress splicing and are typically bound by specific hnRNPs.
“In addition, there are intronic and exonic splicing silencers (ISSs and ESSs, respectively) which repress splicing and are typically bound by specific members of the heterogeneous ribonuclear protein family (hnRNPs).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningExons 2 and 3 do not contain initiator AUG codons and are noncoding.
“Exons 2 and 3 do not contain initiator AUG codons and therefore are noncoding.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMutations of the nonconsensus D2 site that enhance affinity for U1 snRNP result in an excessive splicing phenotype characterized by increased exon 2 inclusion, increased vif mRNA, reduced unspliced viral RNA, and reduced virus production.
“Mutations of the nonconcensus D2 site that have enhanced affinity for U1 snRNP result in an excessive splicing phenotype characterized by increased inclusion of exon 2, increased levels of vif mRNA, reduced levels of unspliced viral RNA, and reduced virus production.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Madsen and Stoltzfus 2006
Not checked in the free run.
- cites Exline et al. 2008
Not checked in the free run.
- cites Mandal et al. 2008
Not checked in the free run.
May combine two claims.
PremisecitationThe Tat switching mechanism depends on autoregulation of Tat; when Tat is expressed in trans from an ectopic promoter, HIV-1 proviruses become constitutively active and unable to enter latency.
“This switching mechanism crucially depends on the autoregulation of Tat; when Tat is expressed in trans from an ectopic promoter, HIV-1 proviruses become constitutively active and are unable to enter latency (Pearson et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pearson et al. 2008
Not checked in the free run.
May combine two claims.
PremisecitationThe first tat coding exon contains two ESS elements, ESS2 and ESS2p, that specifically repress splicing at 3' splice site A3 and reduce levels of both incompletely and completely spliced tat mRNA.
“For example, the first tat coding exon contains two ESS elements (ESS2 and ESS2p) that specifically repress splicing at 3 0 ss A3 and reduce the levels of both incompletely and completely spliced tat mRNA (Jacquenet et al. 2001;Amendt et al. 1994).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Jacquenet et al. 2001
Not checked in the free run.
- cites Amendt et al. 1994
Not checked in the free run.
May combine two claims.
Premisenone givenHIV-1 spliced mRNAs include incompletely spliced bicistronic mRNAs encoding Env and Vpu; incompletely spliced mRNAs for Vif, Vpr, and a truncated 72 aa Tat; and completely spliced mRNAs encoding Tat, Rev, and Nef.
“These include several incompletely spliced bicistronic mRNA species, which encode both Env and Vpu; incompletely spliced mRNAs for Vif, Vpr, and a truncated 72 aa form of Tat; and completely spliced mRNAs that encode the HIV-1 regulatory proteins Tat, Rev, and Nef.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMutations of 5' splice site D2 that decrease affinity for U1 snRNP result in decreased inclusion of exon 2 and decreased levels of vif mRNA and Vif protein.
“Conversely, mutations of 5 0 ss D2 that decrease affinity for U1 snRNP result in decreased inclusion of exon 2 and decreased levels of vif mRNA and Vif protein (Madsen and Stoltzfus 2006;Exline et al. 2008;Mandal et al. 2008).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Madsen and Stoltzfus 2006
Not checked in the free run.
- cites Exline et al. 2008
Not checked in the free run.
- cites Mandal et al. 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenUnspliced and incompletely spliced transcripts from cellular genes are typically degraded in the nucleus.
“Unspliced and incompletely spliced transcripts from cellular genes are typically degraded in the nucleus.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThe order of intrinsic splice site strengths does not correlate with observed levels of mRNAs spliced at these 3' splice sites, implying that cis-acting splicing elements dominate splice site selection of HIV-1 mRNAs.
“However, the order of intrinsic splice site strengths (Asang et al. 2008) does not correlate with the observed levels of mRNAs spliced at these 3 0 splice sites, implying that the cisacting splicing elements dominate the splice site selection of HIV-1 mRNAs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Asang et al. 2008
Not checked in the free run.
May combine two claims.
Premisenone givenThe efficiency of early splicing complex formation is determined by the intrinsic strengths of the 3' splice site and downstream 5' splice site and is further regulated by cis-acting elements.
“The efficiency of early splicing complex formation is determined by the intrinsic strengths of the 3 0 ss and downstream 5.7 1.7 5' Cap D1 A1 ESE-vif G4 motif ESEM Exon1 Exon2 Exon3 Exon4,4c,a,b,5 Exon7 ESSV ESS2p ESE2 ESS2 GAR ESE ISS3 ESS3 ESE2 D2 A2 D3 D4 A5 env/nef A4c,a,b rev A3 A7 tat/rev/nef vpr tat vif tat exon 1,2 rev rev rev nef nef vif vpr tat exon 1 env/vpu env/vpu env/vpu env/vpu 5 0”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRNA splicing is performed while the pre-mRNA is associated with the spliceosome.
“RNA splicing is performed while the pre-mRNA is associated with a large complex of cellular factors referred to as the spliceosome (for recent reviews, see Wang and Burge 2008;Chen and Manley 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Wang and Burge 2008
Not checked in the free run.
- cites Chen and Manley 2009
Not checked in the free run.
May combine two claims.
PremisecitationMutations of the hnRNP A/B-dependent ESSV activated 3' splice site A2 and increased levels of mRNAs containing exon 3 and incompletely spliced vpr mRNA.
“Mutations of the hnRNP A/B-dependent ESS, ESSV, activated 3 0 ss A2 and resulted in increased levels of mRNAs containing exon 3 and the incompletely spliced vpr mRNA.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Madsen and Stoltzfus 2005
Not checked in the free run.
May combine two claims.
PremisecitationThe GAR ESE is selectively bound by several SR proteins, but SF2/ASF is the most important player in its function.
“The GAR ESE is selectively bound by several SR proteins but the most important player in the function of the element is SF2/ASF (Caputi et al. 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Caputi et al. 2004
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenEukaryotic translation starts by scanning from the 5' cap until an initiator AUG in a suitable Kozak context is found.
“Initiation of translation of eukaryotic mRNAs involves scanning from the 5 0 cap until an initiator AUG in an appropriate Kozak consensus sequence is recognized.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationHow much Rev oligomerizes tracks with its capacity to export RNA.
“The degree of oligomerization correlates with the ability of Rev to transport RNA (Fig. 5B,C) (Mann et al. 1994).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mann et al. 1994
Not checked in the free run.
May combine two claims.
PremisecitationThe resulting GTP-to-GDP conversion breaks up the Rev complex and frees factors from the RRE.
“This destabilizes the Rev complex and releases factors from the RRE (Fischer et al. 1995).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fischer et al. 1995
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenCrm1 binds cargo when Ran GTPase is GTP-bound.
“Crm1, like other members of the karyopherin family, binds to cargo in the presence of the GTP-bound form of Ran GTPase.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCrystallography has yielded structures of the Rev dimer amino terminus and of an intact Rev dimer.
“In the culmination of years of effort, recent crystallographic studies have led to the solution of both the amino-terminal structure of the Rev dimer (DiMattia et al. 2010) and an intact Rev dimer (Fig. 5A) (Daugherty et al. 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites DiMattia et al. 2010
Not checked in the free run.
- cites Daugherty et al. 2010
Not checked in the free run.
May combine two claims.
PremisecitationNuclear retention of HIV-1 mRNAs results from cellular factors binding unused 3'ss and 5'ss and from cis-acting repressive or instability sequences.
“Nuclear retention is achieved both because cellular factors bind to unused HIV-1 3 0 ss and 5 0 ss (Chang and Sharp 1989;Borg et al. 1997) and because of cis-acting repressive sequences (CRSs) or instability sequences (INSs).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Chang and Sharp 1989
Not checked in the free run.
- cites Borg et al. 1997
Not checked in the free run.
May combine two claims.
InterpretationreasoningThis arrangement lets the dimer contact neighboring RNA sites and links dimerization to RNA recognition.
“This allows the dimer to bind adjacent RNA sites and structurally couples dimerization and RNA recognition.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationRev assembly on the RRE is strongly cooperative and raises affinity roughly 500-fold over binding to the high-affinity site alone.
“Furthermore, oligomerization of Rev on the RRE is highly cooperative and results in an affinity approximately 500 times higher than Rev binding to the high affinity site alone (Daugherty et al. 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Daugherty et al. 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMetazoan pre-mRNA 3' processing and polyadenylation requires recognition of an upstream AAUAAA and a downstream GU-rich motif around the cleavage and poly(A) addition site.
“The 3 0 processing and polyadenylation of metazoan pre-mRNAs involves recognition of the upstream AAUAAA and downstream GU-rich motifs surrounding the cleavage and poly(A) addition site.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn murine cells, HIV-1 Gag assembly is usually inefficient, but switching the gag-pol mRNA export element from the RRE to the CTE restored Gag membrane trafficking and efficient assembly.
“For example, HIV-1 Gag assembly in murine cells is normally very inefficient, however, altering the RNA nuclear export element used by HIV-1 gag-pol mRNA from the Rev response element to the constitutive transport element (CTE) restored both the trafficking of Gag to cellular membranes and efficient HIV-1 assembly (Swanson et al. 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Swanson et al. 2004
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenCPSF recognizes the AAUAAA signal, while CstF recognizes the GU-rich motif.
“The AAUAAA signal is recognized by the cleavage/polyadenylation specificity factor (CPSF) the GU-rich motif is recognized by CstF.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCleavage requires CF1m, CF2m, and poly(A) polymerase.
“In addition, the cleavage reaction requires mammalian cleavage factors CF1m, CF2m, and poly(A) polymerase (for review, see Colgan and Manley 1997;Millevoi and Vagner 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Colgan and Manley 1997
Not checked in the free run.
- cites Millevoi and Vagner 2010
Not checked in the free run.
May combine two claims.
Premisenone givenTat and Rev are both needed for active HIV-1 replication and for virus emergence from latency.
“especially because Tat and Rev are both required for active viral replication and essential for the emergence of viruses from latency.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningThe second element is a stem-loop pseudoknot just 3' of the heptanucleotide sequence; it pauses the ribosome and lengthens its stay on the slippery sequence.
“The second is a stem-loop pseudoknot structure located just 3 0 to the heptanucleotide sequence that acts as a pause site that increases the time the ribosome is associated with the slippery sequence.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEvidence suggests that SKIP promotes both Tat-mediated transactivation and HIV-1 splicing.
“Evidence that the splicing-associated c-Skiinteracting protein, SKIP, activates both Tat transactivation and HIV-1 splicing provides an intriguing insight into how these diverse events may be coordinated (Bres et al. 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bres et al. 2005
Not checked in the free run.
May combine two claims.
Premisenone givenThe HIV-1 frameshift happens 5% of the time, yielding about one Gag-Pro-Pol precursor per 20 Gag precursors.
“This frameshift occurs 5% of the time and results in the production of about one Gag-Pro-Pol precursor for every 20 Gag precursors synthesized.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenThe first element is a hexanucleotide slippery sequence (UUUUUUA), where slippage occurs during translation.
“The first is a hexanucleotide”
Quote in the paperSubstantial claimMay combine two claims.
Premiseown dataAll HIV-1 env mRNAs are bicistronic, with an upstream vpu ORF overlapping the downstream env ORF.
“Finally, as shown in Figure 1, all HIV-1 env mRNA species are bicistronic and have an upstream vpu open reading frame overlapping the downstream env open reading frame.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRHA, a DEIH helicase, and the RNA-binding proteins SRp40 and SRp55 can enhance Gag translation.
“Gag translation can be enhanced by RHA, a DEIH helicase (Bolinger et al. 2010) as well as the RNA binding proteins SRp40 and SRp55 (Swanson et al. 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Bolinger et al. 2010
Not checked in the free run.
- cites Swanson et al. 2010
Not checked in the free run.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tat protein binds to the trans activation response (TAR) region of HIV-1 RNA for efficient elongation.
“Subsequently, Tat protein is expressed from early double-spliced transcripts and binds to the trans activation response (TAR) region of HIV-1 RNA for its efficient elongation 2 .”
From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus (2013) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The cited figure does not match the env-mRNA claim
MinorThe translation section directs readers to Figure 1 for the arrangement of env and vpu reading frames, but Figure 1 is identified as depicting Tat and P-TEFb interactions.
“Finally, as shown in Figure 1, all HIV-1 env mRNA species are bicistronic and have an upstream vpu open reading frame overlapping the downstream env open reading frame.”
“Figure 1.Tat and its interactions with P-TEFb.”
The 1.8-kb mRNAs receive conflicting splicing classifications
MinorThe text identifies the 1.8-kb mRNAs as completely spliced, whereas the Figure 3 caption groups them with incompletely spliced mRNAs.
“the completely spliced 1.8-kb mRNAs, which encode Tat, Rev, and Nef”
“The exons present in the incompletely spliced 4-kb and 1.8-kb mRNA species corresponding to the HIV-1 genes are shown as cyan rectangles.”
The slippery sequence is assigned two different lengths
MinorThe sequence UUUUUUA has seven nucleotides, and the following sentence calls it a heptanucleotide. Calling it a hexanucleotide is inconsistent with both.
“The first is a hexanucleotide "slippery" sequence (UUUUUUA), which is the actual site of slippage during translation.”
“The second is a stem-loop pseudoknot structure located just 3 0 to the heptanucleotide sequence”
Early-stage viral RNA is described as both limited to spliced forms and inclusive of larger transcripts
MinorThe text says that immediately after infection HIV-1 produces only short, completely spliced mRNAs. Figure 4 instead says that unspliced 9-kb and incompletely spliced 4-kb mRNAs are expressed at early times, though they remain in the nucleus.
“Immediately after infection, HIV-1 produces only short completely spliced mRNAs encoding the viral regulatory proteins Tat and Rev.”
“Full-length unspliced 9-kb, incompletely spliced 4-kb mRNA, and completely spliced 1.8-kb mRNAs are expressed at both early and late times.”
Cites
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G. J., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,076 · see citing works
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Chen, M., & Manley, J. L. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2777 · Cited by 1,284 · see citing works
Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., & Cullen, B. R. (1989) · Nature · doi:10.1038/338254a0 · Cited by 1,280 · see citing works
Wei, P., Garber, M. E., Fang, S.-M., Fischer, W. H., & Jones, K. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80939-3 · Cited by 1,251 · see citing works
Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W., & Lührmann, R. (1995) · Cell · doi:10.1016/0092-8674(95)90436-0 · Cited by 1,140 · see citing works
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Wang, Z., & Burge, C. B. (2008) · RNA · doi:10.1261/rna.876308 · Cited by 1,076 · see citing works
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
Kao, S.-Y., Calman, A. F., Luciw, P. A., & Peterlin, B. M. (1987) · Nature · doi:10.1038/330489a0 · Cited by 908 · see citing works
Yamaguchi, Y., Takagi, T., Wada, T., Yano, K., Furuya, A., Sugimoto, S., Hasegawa, J., & Handa, H. (1999) · Cell · doi:10.1016/s0092-8674(00)80713-8 · Cited by 841 · see citing works
Architecture and secondary structure of an entire HIV-1 RNA genome
Watts, J. M., Dang, K. K., Gorelick, R. J., Leonard, C. W., Bess, J. W., Swanstrom, R. I., Burch, C. L., & Weeks, K. M. (2009) · Nature · doi:10.1038/nature08237 · Cited by 825 · see citing works
Mechanism and regulation of mRNA polyadenylation
Colgan, D. F., & Manley, J. L. (1997) · Genes & Development · doi:10.1101/gad.11.21.2755 · Cited by 784 · see citing works
Exporting RNA from the nucleus to the cytoplasm
Köhler, A., & Hurt, E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2255 · Cited by 780 · see citing works
Pollard, V. W., & Malim, M. H. (1998) · Annual Review of Microbiology · doi:10.1146/annurev.micro.52.1.491 · Cited by 715 · see citing works
Exon definition may facilitate splice site selection in RNAs with multiple exons.
Robberson, B. L., Cote, G. J., & Berget, S. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.1.84 · Cited by 710 · see citing works
7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes
Nguyen, V. T., Kiss, T., Michels, A. A., & Bensaude, O. (2001) · Nature · doi:10.1038/35104581 · Cited by 708 · see citing works
Activation of the AIDS Retrovirus Promoter by the Cellular Transcription Factor, Sp1
Jones, K. A., Kadonaga, J. T., Luciw, P. A., & Tjian, R. (1986) · Science · doi:10.1126/science.3008338 · Cited by 702 · see citing works
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitroPreprint
Zhu, Y., Peery, T., Peng, J., Ramanathan, Y., Marshall, N. F., Marshall, T. K., Amendt, B. A., Mathews, M. B., & Price, D. H. (1997) · Genes & Development · doi:10.1101/gad.11.20.2622 · Cited by 700 · see citing works
The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription
Yang, Z., Zhu, Q., Luo, K., et al. (2001) · Nature · doi:10.1038/35104575 · Cited by 681 · see citing works
Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase
Marshall, N. F., Peng, J., Xie, Z., & Price, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27176 · Cited by 662 · see citing works
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein
Muesing, M. A. (1987) · Cell · doi:10.1016/0092-8674(87)90247-9 · Cited by 660 · see citing works
Tat trans-activates the human immunodeficiency virus through a nascent RNA target
Berkhout, B., Silverman, R. H., & Jeang, K.-T. (1989) · Cell · doi:10.1016/0092-8674(89)90289-4 · Cited by 647 · see citing works
A second post-transcriptional trans-activator gene required for HTLV-III replication
Sodroski, J., Goh, W. C., Rosen, C. A., Dayton, A. I., Terwilliger, E. F., & Haseltine, W. A. (1986) · Nature · doi:10.1038/321412a0 · Cited by 632 · see citing works
Weinberger, L. S., Burnett, J., Toettcher, J. E., Arkin, A. P., & Schaffer, D. V. (2005) · Cell · doi:10.1016/j.cell.2005.06.006 · Cited by 616 · see citing works
α Helix-RNA Major Groove Recognition in an HIV-1 Rev Peptide-RRE RNA Complex
Battiste, J. L., Mao, H., Rao, N. S., Tan, R., Muhandiram, D. R., Kay, L. E., Frankel, A. D., & Williamson, J. R. (1996) · Science · doi:10.1126/science.273.5281.1547 · Cited by 596 · see citing works
Conformation of the TAR RNA-Arginine Complex by NMR Spectroscopy
Puglisi, J. D., Tan, R., Calnan, B. J., Frankel, A. D., & Williamson, J. R. (1992) · Science · doi:10.1126/science.1621097 · Cited by 596 · see citing works
Kim, S. Y., Byrn, R. A., Groopman, J. E., & Baltimore, D. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3708-3713.1989 · Cited by 577 · see citing works
Marshall, N. F., & Price, D. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12335 · Cited by 564 · see citing works
Location of the Trans -Activating Region on the Genome of Human T-Cell Lymphotropic Virus Type III
Sodroski, J., Patarca, R., Rosen, C. A., Wong‐Staal, F., & Haseltine, W. A. (1985) · Science · doi:10.1126/science.2990041 · Cited by 556 · see citing works
HIV-1 tat trans-activation requires the loop sequence within tar
Feng, S., & Holland, E. C. (1988) · Nature · doi:10.1038/334165a0 · Cited by 554 · see citing works
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitroPreprint
Mancebo, H. S. Y., Lee, G., Flygare, J. A., Tomassini, J. E., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D. J., Price, D. H., et al. (1997) · Genes & Development · doi:10.1101/gad.11.20.2633 · Cited by 546 · see citing works
Purcell, D. F. J., & Martin, M. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6365-6378.1993 · Cited by 534 · see citing works
Regulation by HIV Rev depends upon recognition of splice sites
Chang, D. D., & Sharp, P. A. (1989) · Cell · doi:10.1016/0092-8674(89)90602-8 · Cited by 518 · see citing works
Verdin, E. M., Paras, P., & Lint, C. M. V. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05994.x · Cited by 515 · see citing works
HIV LatencyPreprint
Siliciano, R. F., & Greene, W. C. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007096 · Cited by 509 · see citing works
Sodroski, J., Rosen, C. A., Wong‐Staal, F., Salahuddin, S. Z., Popovič, M., Arya, S. K., Gallo, R. C., & Haseltine, W. A. (1985) · Science · doi:10.1126/science.2981427 · Cited by 493 · see citing works
A cooperative interaction between NF‐kappa B and Sp1 is required for HIV‐1 enhancer activation.
Perkins, N. D., Edwards, N. L., Duckett, C. S., Agranoff, A. B., Schmid, R. M., & Nabel, G. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06029.x · Cited by 484 · see citing works
Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D., Singh, M., Skinner, M. A., & VALERIO, R. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6925 · Cited by 476 · see citing works
Self-citationYik, J. H. N., Chen, R., Nishimura, R., Jennings, J. L., Link, A. J., & Zhou, Q. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00388-5 · Cited by 464 · see citing works
Jerónimo, C., Forget, D., Bouchard, A., Li, Q., Chua, G., Poitras, C., Thérien, C., Bergeron, D., Bourassa, S., Greenblatt, J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.027 · Cited by 444 · see citing works
Garber, M. E., Wei, P., KewalRamani, V. N., Mayall, T. P., Herrmann, C. H., Rice, A. P., Littman, D. R., & Jones, K. A. (1998) · Genes & Development · doi:10.1101/gad.12.22.3512 · Cited by 430 · see citing works
Yamada, T., Yamaguchi, Y., Inukai, N., Okamoto, S., Mura, T., & Handa, H. (2006) · Molecules and Cells · doi:10.1016/j.molcel.2005.11.024 · Cited by 421 · see citing works
Malim, M. H., & Cullen, B. R. (1991) · Cell · doi:10.1016/0092-8674(91)90158-u · Cited by 420 · see citing works
Dingwall, C., Ernberg, I., Gait, M. J., et al. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07637.x · Cited by 411 · see citing works
He, N., Liu, M., Hsu, J. H., Xue, Y., Chou, S., Burlingame, A. L., Krogan, N. J., Alber, T., & Zhou, Q. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.013 · Cited by 396 · see citing works
Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation
Millevoi, S., & Vagner, S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1176 · Cited by 391 · see citing works
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Lévy, Y., Kiernan, R. E., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 382 · see citing works
Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro
Daly, T. J., Cook, K. S., Gray, G. S., Maione, T. E., & Rusche, J. R. (1989) · Nature · doi:10.1038/342816a0 · Cited by 375 · see citing works
Fujinaga, K., Irwin, D., Huang, Y.-H., Taube, R., Kurosu, T., & Peterlin, B. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.787-795.2004 · Cited by 374 · see citing works
Aboul‐ela, F., Karn, J., & Varani, G. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0555 · Cited by 369 · see citing works
Self-citationPomerantz, R. J., Trono, D., Feinberg, M. B., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90691-7 · Cited by 365 · see citing works
Retroviral DNA integration: viral and cellular determinants of target-site selection
Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020060 · Cited by 364 · see citing works
Selby, M., Bain, E. S., Luciw, P. A., & Peterlin, B. M. (1989) · Genes & Development · doi:10.1101/gad.3.4.547 · Cited by 342 · see citing works
Heaphy, S., Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Kern, J., Lowe, A. D., Singh, M., & Skinner, M. A. (1990) · Cell · doi:10.1016/0092-8674(90)90671-z · Cited by 342 · see citing works
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
Bosque, A., & Planelles, V. (2008) · Blood · doi:10.1182/blood-2008-07-168393 · Cited by 335 · see citing works
Herrmann, C. H., & Rice, A. P. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1612-1620.1995 · Cited by 335 · see citing works
Crystal structure of HIV-1 Tat complexed with human P-TEFb
Tahirov, T. H., Babayeva, N. D., Varzavand, K., Cooper, J. J., Sedore, S. C., & Price, D. H. (2010) · Nature · doi:10.1038/nature09131 · Cited by 314 · see citing works
Binding of the 7SK snRNA turns the HEXIM1 protein into a P‐TEFb (CDK9/cyclin T) inhibitor
Michels, A. A., Fraldi, A., Li, Q., Adamson, T. E., Bonnet, F., Nguyen, V. T., Sedore, S. C., Price, J. P., Price, D. H., Lania, L., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600275 · Cited by 305 · see citing works
Nuclear mRNA export: insights from virology
Cullen, B. R. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00142-7 · Cited by 300 · see citing works
Pearson, R., Kim, Y. K., Hokello, J. F., Lassen, K. G., Friedman, J. H., Tyagi, M., & Karn, J. (2008) · Journal of Virology · doi:10.1128/jvi.01383-08 · Cited by 299 · see citing works
Self-citationChurcher, M. J., Lamont, C., Hamy, F., et al. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1128 · Cited by 289 · see citing works
Garcia, J. A., Harrich, D., Soultanakis, E., et al. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03437.x · Cited by 283 · see citing works
Exon Definition May Facilitate Splice Site Selection in RNAs with Multiple Exons
Robberson, B. L., Cote, G. J., & Berget, S. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.1.84-94.1990 · Cited by 282 · see citing works
Schwartz, S., Felber, B. K., & Pavlakis, G. N. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.150-159.1992 · Cited by 265 · see citing works
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., & Cullen, B. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.7056 · Cited by 260 · see citing works
Henderson, B. R., & Percipalle, P. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1420 · Cited by 257 · see citing works
Zapp, M. L., Hope, T. J., Parslow, T. G., & Green, M. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7734 · Cited by 252 · see citing works
Krueger, B. J., Jerónimo, C., Roy, B. B., Bouchard, A., Barrandon, C., Byers, S. A., Searcey, C. E., Cooper, J. J., Bensaude, O., Cohen, É. A., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn061 · Cited by 245 · see citing works
He, N., Jahchan, N. S., Hong, E. M., Li, Q., Bayfield, M. A., Maraia, R. J., Luo, K., & Zhou, Q. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.01.003 · Cited by 236 · see citing works
Yamaguchi, Y., Inukai, N., Narita, T., Wada, T., & Handa, H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2918-2927.2002 · Cited by 235 · see citing works
Alcamı́, J., de Lera, T. L., Folgueira, M. D., Pedraza, M. A., Jacqué, J. M., Bachelerie, F., Noriega, A. R., Hay, R. T., Harrich, D., & Gaynor, R. B. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07141.x · Cited by 231 · see citing works
Narita, T., Yamaguchi, Y., Yano, K., Sugimoto, S., Chanarat, S., Wada, T., Kim, D.-K., Hasegawa, J., Omori, M., Inukai, N., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1863-1873.2003 · Cited by 230 · see citing works
Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells
Kinoshita, S. M., Chen, B. K., Kaneshima, H., & Nolan, G. P. (1998) · Cell · doi:10.1016/s0092-8674(00)81630-x · Cited by 228 · see citing works
Sung, T.-L., & Rice, A. P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000263 · Cited by 227 · see citing works
Hoffman, B. E., & Grabowski, P. J. (1992) · Genes & Development · doi:10.1101/gad.6.12b.2554 · Cited by 226 · see citing works
Domains in the SPT5 Protein That Modulate Its Transcriptional Regulatory Properties
Ivanov, D., Kwak, Y. T., Guo, J. Q., & Gaynor, R. B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.2970-2983.2000 · Cited by 222 · see citing works
Mann, D. A., Mikaélian, I., Zemmel, R. W., Green, S. M., Lowe, A. D., Kimura, T., Singh, M., Jonathan, P., Butler, G., Gait, M. J., et al. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1488 · Cited by 188 · see citing works
Self-citationTat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription
Barborič, M., Yik, J. H. N., Czudnochowski, N., Yang, Z., Chen, R., Contreras, X., Geyer, M., Peterlin, B. M., & Zhou, Q. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm063 · Cited by 188 · see citing works
Davidson, A. I., Leeper, T. C., Athanassiou, Z., Patora‐Komisarska, K., Karn, J., Robinson, J. A., & Varani, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900629106 · Cited by 179 · see citing works
Self-citationKarn, J. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328340ffbb · Cited by 178 · see citing works
Self-citationKim, Y. K., Bourgeois, C. F., Isel, C., Churcher, M. J., & Karn, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4622-4637.2002 · Cited by 178 · see citing works
Self-citationProgrammed ribosomal frameshifting in HIV-1 and the SARS–CoV
Brierley, I., & Ramos, F. J. D. (2005) · Virus Research · doi:10.1016/j.virusres.2005.10.008 · Cited by 168 · see citing works
Fujinaga, K., Cujec, T. P., Peng, J., Garriga, J., Price, D. H., Graña, X., & Peterlin, B. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7154-7159.1998 · Cited by 165 · see citing works
Structural basis for cooperative RNA binding and export complex assembly by HIV Rev
Daugherty, M. D., Liu, B., & Frankel, A. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1902 · Cited by 162 · see citing works
Sedore, S. C., Byers, S. A., Biglione, S., Price, J. P., Maury, W. J., & Price, D. H. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm443 · Cited by 157 · see citing works
Chapter 1 Regulation of HIV-1 Alternative RNA Splicing and Its Role in Virus Replication
Stoltzfus, C. M. (2009) · Advances in virus research · doi:10.1016/s0065-3527(09)74001-1 · Cited by 154 · see citing works
Self-citationThree RNA Polymerase II Carboxyl-terminal Domain Kinases Display Distinct Substrate Preferences
Ramanathan, Y., Rajpara, S. M., Reza, S. M., Lees, E. M., Shuman, S., Mathews, M. B., & Pe’ery, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010975200 · Cited by 148 · see citing works
Stoltzfus, C. R., & Madsen, J. (2005) · Current HIV Research · doi:10.2174/157016206775197655 · Cited by 143 · see citing works
Self-citationSolution structure of the HIV-2 TAR-argininamide complex
Brodsky, A. S., & Williamson, J. R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0879 · Cited by 142 · see citing works
Retroviral mRNA nuclear export elements regulate protein function and virion assembly
Swanson, C. M., Puffer, B. A., Ahmad, K. M., Doms, R. W., & Malim, M. H. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600270 · Cited by 141 · see citing works
DiMattia, M. A., Watts, N. R. M., Stahl, S. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914946107 · Cited by 134 · see citing works
Jacquenet, S., Méreau, A., Bilodeau, P. S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104070200 · Cited by 132 · see citing works
RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions
Bolinger, C., Sharma, A., Singh, D., Yu, L., & Boris‐Lawrie, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1075 · Cited by 132 · see citing works
Isel, C., & Karn, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2933 · Cited by 131 · see citing works
Self-citationAmendt, B. A., Hesslein, D., Chang, L., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3960-3970.1994 · Cited by 130 · see citing works
Gilmartin, G. M., Fleming, E. S., Oetjen, J., & Graveley, B. R. (1995) · Genes & Development · doi:10.1101/gad.9.1.72 · Cited by 128 · see citing works
The retrovirus RNA trafficking granule: from birth to maturity
Cochrane, A., McNally, M. T., & Mouland, A. J. (2006) · Retrovirology · doi:10.1186/1742-4690-3-18 · Cited by 127 · see citing works
Daugherty, M. D., D’Orso, I., & Frankel, A. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.016 · Cited by 127 · see citing works
Zolotukhin, A. S., Michałowski, D., Bear, J., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6618-6630.2003 · Cited by 127 · see citing works
Ashe, M. P., Griffin, P., James, W., & Proudfoot, N. J. (1995) · Genes & Development · doi:10.1101/gad.9.23.3008 · Cited by 125 · see citing works
Bilodeau, P. S., Domsic, J. K., Mayeda, A., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8487-8497.2001 · Cited by 119 · see citing works
Bourgeois, C. F., Kim, Y. K., Churcher, M. J., West, M. J., & Karn, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1079-1093.2002 · Cited by 118 · see citing works
Self-citationBrès, V., Gomes, N. P., Pickle, L., et al. (2005) · Genes & Development · doi:10.1101/gad.1291705 · Cited by 118 · see citing works
Krueger, B. J., Varzavand, K., Cooper, J. J., & Price, D. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012335 · Cited by 111 · see citing works
Bolinger, C., & Boris‐Lawrie, K. (2009) · Retrovirology · doi:10.1186/1742-4690-6-8 · Cited by 111 · see citing works
Chen, B. K., Feinberg, M. B., & Baltimore, D. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5495-5504.1997 · Cited by 108 · see citing works
Zhang, Z., Klatt, A., Gilmour, D. S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610688200 · Cited by 107 · see citing works
Das, A. T., Klaver, B., & Berkhout, B. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.81-91.1999 · Cited by 107 · see citing works
Control of Stochastic Gene Expression by Host Factors at the HIV Promoter
Burnett, J., Miller‐Jensen, K., Shah, P. S., Arkin, A. P., & Schaffer, D. V. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000260 · Cited by 103 · see citing works
Structure of NFAT1 bound as a dimer to the HIV-1 LTR κB element
Giffin, M. J., Stroud, J. C., Bates, D. L., von Koenig, K. D., Hardin, J., & Chen, L. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb981 · Cited by 102 · see citing works
Liu, J., Perkins, N. D., Schmid, R. M., et al. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3883-3887.1992 · Cited by 101 · see citing works
Cellular Proteins and HIV-1 Rev Function
Suhasini, M., & Reddy, T. R. (2009) · Current HIV Research · doi:10.2174/157016209787048474 · Cited by 101 · see citing works
Caputi, M., Freund, M., Kammler, S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6517-6526.2004 · Cited by 97 · see citing works
An HIV Feedback Resistor: Auto-Regulatory Circuit Deactivator and Noise Buffer
Weinberger, L. S., & Shenk, T. E. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0050009 · Cited by 89 · see citing works
Mechanisms of HIV Latency: an Emerging Picture of Complexity
Margolis, D. M. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0033-9 · Cited by 89 · see citing works
Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation
Kwak, Y. T., Ivanov, D., Guo, J. Q., Nee, E., & Gaynor, R. B. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2664 · Cited by 89 · see citing works
Chen-Park, F. E., Huang, D.-B., Noro, B., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200007200 · Cited by 86 · see citing works
Acetylation of cyclin T1 regulates the equilibrium between active and inactive P‐TEFb in cells
Cho, S., Schroeder, S., Kaehlcke, K., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.99 · Cited by 73 · see citing works
The strength of the HIV-1 3' splice sites affects Rev function
Kammler, S., Otte, M., Hauber, I., et al. (2006) · Retrovirology · doi:10.1186/1742-4690-3-89 · Cited by 69 · see citing works
SRp40 and SRp55 Promote the Translation of Unspliced Human Immunodeficiency Virus Type 1 RNA
Swanson, C. M., Sherer, N. M., & Malim, M. H. (2010) · Journal of Virology · doi:10.1128/jvi.02526-09 · Cited by 68 · see citing works
Stem-loop 1 of the U1 snRNP plays a critical role in the suppression of HIV-1 polyadenylation
Ashe, M., Furger, A., & Proudfoot, N. J. (2000) · RNA · doi:10.1017/s1355838200991957 · Cited by 68 · see citing works
Najera, I., Krieg, M., & Karn, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2473 · Cited by 67 · see citing works
Self-citationAfonina, E., Neumann, M., & Pavlakis, G. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2307 · Cited by 66 · see citing works
Herrmann, C. H., Gold, M. O., & Rice, A. P. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.3.501 · Cited by 66 · see citing works
Rittner, K., Churcher, M. J., Gait, M. J., et al. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0243 · Cited by 65 · see citing works
Exline, C. M., Feng, Z., & Stoltzfus, C. M. (2008) · Journal of Virology · doi:10.1128/jvi.01558-07 · Cited by 65 · see citing works
Self-citationZenzie-Gregory, B., Sheridan, P. L., Jones, K. A., et al. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82328-6 · Cited by 64 · see citing works
Madsen, J. M., & Stoltzfus, C. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10478-10486.2005 · Cited by 64 · see citing works
Self-citationAmendt, B. A., Hesslein, D., Chang, L. J., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3960 · Cited by 64 · see citing works
Characterization of Cdk9 T-loop phosphorylation in resting and activated CD4+ T lymphocytes
Ramakrishnan, R., Dow, E. C., & Rice, A. P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0509309 · Cited by 60 · see citing works
HIV-1 mRNA 3′ End Processing Is Distinctively Regulated by eIF3f, CDK11, and Splice Factor 9G8
Valente, S. T., Gilmartin, G. M., Venkataraman, K., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.004 · Cited by 57 · see citing works
Madsen, J. M., & Stoltzfus, C. M. (2006) · Retrovirology · doi:10.1186/1742-4690-3-10 · Cited by 52 · see citing works
Self-citationKrummheuer, J., Johnson, A. T., Hauber, I., Kammler, S., Anderson, J. L., Hauber, J., Purcell, D. F. J., & Schaal, H. (2007) · Virology · doi:10.1016/j.virol.2007.01.022 · Cited by 49 · see citing works
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Burge, C. B., & Wang, Z. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/bzpx-7662 · Cited by 49 · see citing works
Asang, C., Hauber, I., & Schaal, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1147 · Cited by 46 · see citing works
Sherer, N. M., Swanson, C. M., Papaioannou, S., & Malim, M. H. (2009) · Journal of Virology · doi:10.1128/jvi.00699-09 · Cited by 42 · see citing works
HIV-1 Matrix Dependent Membrane Targeting Is Regulated by Gag mRNA Trafficking
Jin, J., Sturgeon, T., Weisz, O. A., Mothes, W., & Montelaro, R. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006551 · Cited by 37 · see citing works
Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements
Black, A. C., Luo, J., Chun, S., Bakker, A., Fraser, J., & Rosenblatt, J. D. (1996) · Virus Genes · doi:10.1007/bf00284648 · Cited by 35 · see citing works
Mandal, D., Feng, Z., & Stoltzfus, C. M. (2007) · Journal of Virology · doi:10.1128/jvi.02295-07 · Cited by 22 · see citing works
Self-citationHow does the journey affect the message(RNA)?
Cochrane, A. (2009) · RNA Biology · doi:10.4161/rna.6.2.8095 · Cited by 12 · see citing works
Borg, K. T., Favaro, J., & Arrigo, S. J. (1997) · Virology · doi:10.1006/viro.1997.8726 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013) · Scientific Reports · doi:10.1038/srep02510 · Cited by 565 · see citing works
Martrus, G., Nevot, M., Andres, C., Clotet, B., & Martinez, M. A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-78 · Cited by 85 · see citing works
Winans, S., & Goff, S. P. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009147 · Cited by 29 · see citing works
Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication
Jehad, M. A., Ali, L. M., Pillai, V. N., Prabhu, S. G., Mustafa, F., & Rizvi, T. A. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf066 · Cited by 5 · see citing works
“R eg u l a t o r y a n d a cc e ss o r y p r o t e i n s o f c o m p l e x r e t r o v i r u s e s . ements required for transcript initiation from the provirus (Cullen et al. 1985 , Graves et al. 1985 , Coffin 1997 , van Opijnen et al. 2004 , Karn and Stoltzfus 2012 ).”
- Authors
- Karn, J., & Stoltzfus, C. M.
- Affiliations
- Case Western Reserve University (US)
- University of Iowa (US)
- Corresponding author
- Karn, J.
- ORCID
- Karn, J.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-11-30
- Volume
- 2
- Issue
- 2
- Pages
- a006916-a006916
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC3281586
- OpenAlex
- W2122660117
- Cited by
- 437
- References
- 139
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 28 · 2023: 31 · 2022: 31 · 2021: 29 · 2020: 27 · 2019: 32 · 2018: 64 · 2017: 31 · 2016: 36 · 2015: 40 · 2014: 25 · 2013: 19 · 2012: 15
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- HIV-1 gene expression, Tat, Rev, P-TEFb, transcription elongation, post-transcriptional regulation, mRNA splicing, unspliced mRNA, nuclear export, viral regulatory proteins
- MeSH terms
- Humans, RNA Splicing, RNA, Viral, Transcription Factors, Transcription, Genetic, Virus Activation, Virus Replication, HIV-1, HIV Infections, Gene Expression, Genes, Suppressor, Feedback, Physiological, Polyadenylation, rev Gene Products, Human Immunodeficiency Virus, tat Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review